2-(3-Oxo-1,2,3,4-tetrahydroquinoxalin-2-yl)acetic acid
95%
- Product Code: 221512
CAS:
136584-14-0
Molecular Weight: | 206.2 g./mol | Molecular Formula: | C₁₀H₁₀N₂O₃ |
---|---|---|---|
EC Number: | MDL Number: | MFCD00219236 | |
Melting Point: | Boiling Point: | 526.6°C | |
Density: | Storage Condition: | Room temperature, dry |
Product Description:
Used in pharmaceutical research as a key intermediate in the synthesis of biologically active compounds, particularly in the development of kinase inhibitors and anti-inflammatory agents. Its structure supports the design of molecules with enhanced binding affinity to specific enzyme targets. Also explored in the preparation of heterocyclic compounds for potential use in central nervous system therapies. Shows utility in medicinal chemistry for optimizing drug candidates due to its rigid cyclic framework and functional group compatibility.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
1g | 10-20 days | ฿75,200.00 |
+
-
|
2-(3-Oxo-1,2,3,4-tetrahydroquinoxalin-2-yl)acetic acid
Used in pharmaceutical research as a key intermediate in the synthesis of biologically active compounds, particularly in the development of kinase inhibitors and anti-inflammatory agents. Its structure supports the design of molecules with enhanced binding affinity to specific enzyme targets. Also explored in the preparation of heterocyclic compounds for potential use in central nervous system therapies. Shows utility in medicinal chemistry for optimizing drug candidates due to its rigid cyclic framework and functional group compatibility.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :